Save
PB0991 Clinical Performance Evaluation of a New Stago System for Antithrombin Levels Determination: sthemO AT on sthemO 301
ISTH Academy, Faculty / Presenters, 407607
PB0993 Thromboelastometry (ROTEM) in Detection of Hypercoagulability in Patients Referred for Thrombophilia Screening
ISTH Academy, Faculty / Presenters, 407608
PB0989 The Efficacy and Safety of Direct Oral Anticoagulants in 50 Patients with Venous Thromboembolism and Severe Thrombophilia: A Multicenter Study
ISTH Academy, Faculty / Presenters, 407609
PB0988 Homozygous Protein S Deficiency in Siblings
ISTH Academy, Faculty / Presenters, 407610
PB0987 Hereditary Antithrombin Deficiency Pilot Project Registry from the American Thrombosis and Hemostasis Network (ATHN)
ISTH Academy, Faculty / Presenters, 407611
PB0985 Cure of Congenital Purpura Fulminant by Neonatal Genome Editing to Express an Engineered Protein C in Mice
ISTH Academy, Faculty / Presenters, 407612
PB0986 Genotype-Phenotype Correlation in Belgian Patients with Inherited Protein C Deficiency
ISTH Academy, Faculty / Presenters, 407613
PB0455 Bilateral Asynchronous Adrenal Infarction in JAK2-Positive Essential Thrombocythemia
ISTH Academy, Faculty / Presenters, 407614
PB0454 Incidence and Predictors of Portal Vein Thrombosis and Mortality in Patients with Liver Cirrhosis: A Retrospective Matched Case-Control Two-Centre Study
ISTH Academy, Faculty / Presenters, 407615
PB0453 Efficacy and Safety of Direct Oral Anticoagulants in Splanchnic Vein Thrombosis: A Pooed Analysis of Literature Studies
ISTH Academy, Faculty / Presenters, 407616
PB0452 Glycemic Control and Plasma Levels of Pro-Inflammatory and Pro- Thrombotic Biomarkers in Diabetic Patients Presenting with Acute Pulmonary Embolism
ISTH Academy, Faculty / Presenters, 407617
PB1029 Exophthalmos Revealing a Rare Cause of Thromboembolic Disease
ISTH Academy, Faculty / Presenters, 407618
PB1027 Delayed Diagnosis and Treatment of Deep Vein Thrombosis-an Underrecognized Factor for Its Related Complications?
ISTH Academy, Faculty / Presenters, 407619
PB1025 Evaluation of a New Stago System for D-Dimer Levels Determination: SthemO DDi on sthemO 301
ISTH Academy, Faculty / Presenters, 407620
PB1022 MicroRNAs Expression before and after Exercise in Patients with Residual Thrombosis after Pulmonary Embolism
ISTH Academy, Faculty / Presenters, 407621
PB1023 Seasonal Variations Regarding Incidence of CTPA Confirmed Pulmonary Embolism in Belfast, N Ireland, from 2014 to 2022
ISTH Academy, Faculty / Presenters, 407622
PB1016 Case-Control Study on Dynamic Upper Limb Ultrasound and Biomarkers in Idiopathic Upper Extremity Deep Vein Thrombosis
ISTH Academy, Faculty / Presenters, 407623
PB1017 Incidence of Pulmonary Embolism-Related Death in Clinical Inpatients Based on ISTH Standardized Recommendation Criteria
ISTH Academy, Faculty / Presenters, 407624
PB1018 Inter-Relationship of Adhesion Molecules with Thrombo-Inflammatory Processes in Pulmonary Embolism
ISTH Academy, Faculty / Presenters, 407625
PB1019 Real-Time Identification of Patients Diagnosed with Pulmonary Embolism in the Emergency Department Using Automated Natural Language Processing of Computed Tomography Reports
ISTH Academy, Faculty / Presenters, 407626
PB1020 Simultaneous Generation of Thrombin and Plasmin in Patients with Deep Vein Thrombosis and High Levels of Lipoprotein (a)
ISTH Academy, Faculty / Presenters, 407627
PB1021 Using an Age and Fibrinogen Levels Adjusted D-Dimer Cutoff Significantly Improves the Specificity of D-Dimer Testing for Excluding Pulmonary Embolism
ISTH Academy, Faculty / Presenters, 407628
PB1013 Evaluation of the Diagnostic Performance of Three D-Dimer Assays in Patients with Suspected Deep Vein Thrombosis
ISTH Academy, Faculty / Presenters, 407629
PB1014 The Optimal Cutoff of NT-proBNP for the Risk-Stratification of Hemodynamically Stable Patients with Acute Pulmonary Embolism
ISTH Academy, Faculty / Presenters, 407630
PB1015 Venous Thromboembolism in Patients with Newly Diagnosed Lymphoma and Its Association with ThroLy and Khorana Risk Scores
ISTH Academy, Faculty / Presenters, 407631
PB1010 Exercise Could Reveal Pulmonary Vascular Abnormalities in Patients with Chronic Thromboembolic Pulmonary Disease - A Hemodynamic Study
ISTH Academy, Faculty / Presenters, 407632
PB1011 Research on the Novel Biomarkers of Extracellular Vesicles in the Diagnosis of Post-Traumatic Deep Vein Thrombosis
ISTH Academy, Faculty / Presenters, 407633
PB1007 Diagnostic Yield of Imaging for Pulmonary Embolism by Presenting Complaint in the Emergency Department: An Observational Study
ISTH Academy, Faculty / Presenters, 407634
PB1008 The Diagnostic Performance of the YEARS and PEGeD Algorithm in Patients with Prior Venous Thrombosis Suspected of Pulmonary Embolism
ISTH Academy, Faculty / Presenters, 407635
PB1006 Accuracy and Interrater Agreement of Death Event Adjudications by Physician Trainees: Validation of the ISTH Definition of Pulmonary Embolism-Related Death in an Autopsy Cohort
ISTH Academy, Faculty / Presenters, 407636
PB1470 Prognostic Value of Determination of Genes Mutations in Patients with Pulmonary Thrombembolism - Multicentre Cohort Study
ISTH Academy, Faculty / Presenters, 407637
PB1466 Early Mortality in Pulmonary Embolism - A Systematic Review and Analysis
ISTH Academy, Faculty / Presenters, 407638
PB1467 Hospital-Acquired (HA) versus Post-Discharge (PD) Venous Thromboembolism (VTE) Similarities and Differences: Analysis of the Medical Inpatient Thrombosis and Hemostasis (MITH) Population
ISTH Academy, Faculty / Presenters, 407639
PB1464 Health literacy among Anticoagulated Patients from a Specialized Unit and Its Impact on Treatment
ISTH Academy, Faculty / Presenters, 407640
PB1465 Venous Thromboembolism in Hospitals Belonging to APHP: A Retrospective Cross-Sectional Study Using the Hospital Discharge Database (PMSI) from Clinical Data Warehouse
ISTH Academy, Faculty / Presenters, 407641
PB1463 Clinical Predictors of In-Hospital Mortality in Patients with Acute Pulmonary Embolism: 15-Years Experience in a Single Center in Argentina
ISTH Academy, Faculty / Presenters, 407642
PB1461 Peri-Operative Venous Thromboembolism (VTE) Risk for Below Knee Amputations
ISTH Academy, Faculty / Presenters, 407643
PB1462 The Safety of Anticoagulation in Electroconvulsive Therapy - A Systematic Review
ISTH Academy, Faculty / Presenters, 407644
PB1459 A Decreased Endogenous Thrombin Potential is Associated with Recurrent Venous Thromboembolism
ISTH Academy, Faculty / Presenters, 407645
PB1460 Venous Anomalies - An Under-Recognised but Important Cause of Venous Thromboembolism (VTE)
ISTH Academy, Faculty / Presenters, 407646
PB1457 The Care Pathway of Patients Diagnosed with Venous Thromboembolism in Emergency Departments: A Retrospective Cross-Sectional Study Using the AP-HP Hospitals Warehouse Hospital Discharge Database
ISTH Academy, Faculty / Presenters, 407647
PB1455 Incidence of Recurrence and Bleeding Rates in Isolated Superficial Vein Thrombosis. Findings from the TROLL Registry
ISTH Academy, Faculty / Presenters, 407648
PB1456 The Impact of Heart Rate on the Prediction of Mortality in Patients with Acute Pulmonary Embolism
ISTH Academy, Faculty / Presenters, 407649
PB1453 Clinical Course and Long-Term Outcomes of Cerebral Venous Sinus Thrombosis in Asians
ISTH Academy, Faculty / Presenters, 407650
PB1451 Chronic Inflammatory Diseases Increase the Risk of Recurrent Venous Thromboembolism Irrespective of Anti-Inflammatory Treatment
ISTH Academy, Faculty / Presenters, 407651
PB1452 Hemorrhagic and Thrombotic Complications in Patients Receiving Therapeutic Plasma Exchange
ISTH Academy, Faculty / Presenters, 407652
PB1501 Devising a Neurosciences-Specific Venous Thromboembolism Risk Assessment Method Balancing Thrombotic and Hemorrhagic Risks
ISTH Academy, Faculty / Presenters, 407653
PB1500 In-Hospital Vein Thromboembolism Prevention in Patients with Atrial Fibrillation
ISTH Academy, Faculty / Presenters, 407654
PB1499 Reducing Hospital Acquired Thrombosis in Wales - A National Approach
ISTH Academy, Faculty / Presenters, 407655
PB1498 Risk of Venous Thromboembolic Disease and Adequacy of Prophylaxis in Hospitalized Cancer Patients in Uruguay
ISTH Academy, Faculty / Presenters, 407656
PB1495 Comfort and Experiences Providing Care to Transgender Youth Among Hematologists in the Midwestern United States
ISTH Academy, Faculty / Presenters, 407657
PB1496 Effect of Atorvastatin on NF-κB and D-dimer in High Risk Thrombosis Cancer Patients Undergoing Chemotherapy
ISTH Academy, Faculty / Presenters, 407658
PB1497 Patients Prefer Oral Agents Over Subcutaneous Injections for Thromboprophylaxis following Hip Fracture Surgery
ISTH Academy, Faculty / Presenters, 407659
PB1490 Mesoglycan versus Placebo in Secondary Prevention of Superficial Vein Thrombosis. Rationale and Protocol
ISTH Academy, Faculty / Presenters, 407660
PB1491 Prevention of Venous Thromboembolism after Thermal Methods of Treatment of Lower Extremity Varicose Vein Disease
ISTH Academy, Faculty / Presenters, 407661
PB1489 Clinician and Informaticist Perceptions on the Potential for Artificial Intelligence to Improve Venous Thromboembolism Management
ISTH Academy, Faculty / Presenters, 407662
PB1488 Risk of Venous Thromboembolic Disease and Adequacy of Thromboprophylaxis at a Teaching Hospital and Incidence of VTE in the Three Months after Admission
ISTH Academy, Faculty / Presenters, 407663
PB1485 Patients' Knowledge about Venous Thromboembolism and Oral Anticoagulation Increases the Risk of Clinical Outcomes during Long-Term Follow-up
ISTH Academy, Faculty / Presenters, 407664
PB1486 Quality of Anticoagulation Management in Patients Receiving Warfarin at Private Cardiac Centers in Addis Ababa, Ethiopia
ISTH Academy, Faculty / Presenters, 407665
PB1487 Venous Thromboembolism and Major Bleeding Risk in Hospitalized Obese Patients Receiving Thromboprophylaxis with Enoxaparin
ISTH Academy, Faculty / Presenters, 407666
PB1483 Right Needle, Right Patient, Right Time? A National Flash-Mob Audit of Thromboprophylaxis of Cancer Inpatients Receiving Palliative Care
ISTH Academy, Faculty / Presenters, 407667
PB1484 The Use of Artificial Intelligence for Preventing Venous Thromboembolism in Hospitalized Patients: A National Qualitative Study
ISTH Academy, Faculty / Presenters, 407668
PB1481 Evaluation of the Usage of an Electronic Venous Thromboembolism Assessment Tool for Ambulatory Oncology Patients at a Canadian Community Cancer Centre
ISTH Academy, Faculty / Presenters, 407669
PB1482 Thrombelastography Identifies Persistent Platelet-Mediated Hypercoagulability in Patients with Metastatic Bone Disease Requiring Orthopaedic Surgery
ISTH Academy, Faculty / Presenters, 407670
PB1477 An Early Coagulation Factor Dominant Hypercoagulability is followed by a Prolonged Platelet-Dominant Hypercoagulability in Patients with Hip Fracture
ISTH Academy, Faculty / Presenters, 407671
PB1478 Attributes of Randomized Controlled Trials and Their Associations with Funding Sources in Venous Thromboembolism Prophylaxis for Patients with Cancer: A Bibliographical Analysis
ISTH Academy, Faculty / Presenters, 407672
PB1474 Analysis of Thromboprophylaxis Prescribing Using a Cohort Extraction and Information Retrieval Platform, a UK Experience
ISTH Academy, Faculty / Presenters, 407673
PB1475 Network Meta-Analysis Identifies a Care Gap in Optimizing Thromboprophylaxis Following Hip Fracture Surgery
ISTH Academy, Faculty / Presenters, 407674
PB1476 Occurrence of Hospital-Associated Thrombosis Despite Thromboprophylaxis in the Setting of Current Thromboprophylaxis Strategies: An Observational Cross-Sectional Study
ISTH Academy, Faculty / Presenters, 407675
PB1471 Age- and Sex Specific Risks of Major Cardiovascular Complications and Death following Elective Hip and Knee Arthroplasty in the Netherlands: A Dutch Hospital Data Registry Study
ISTH Academy, Faculty / Presenters, 407676
PB1472 One-Week versus Extended Antithrombotic Prophylaxis after Laparoscopic Surgery for Colorectal Cancer: An Individual Patient Meta-Analysis
ISTH Academy, Faculty / Presenters, 407677
PB0515 MAC Project—Monitoring Anticoagulant Therapy Observational Study: Rationale and Protocol
ISTH Academy, Faculty / Presenters, 407678
PB0512 Impact of the Pandemic on Anticoagulant Therapy - Preliminary Study
ISTH Academy, Faculty / Presenters, 407679
PB0514 Report of Clinical Case: Glanzmann Thrombasthenia and Vein Thrombosis
ISTH Academy, Faculty / Presenters, 407680
PB0510 Primary Care Clinician Perceptions and Use of Reduced-Dose Direct Oral Anticoagulants for Extended Phase Venous Thromboembolism Treatment
ISTH Academy, Faculty / Presenters, 407681
PB0511 Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure
ISTH Academy, Faculty / Presenters, 407682
PB0506 Clinical Outcomes of Patients Prescribed Apixaban in End Stage Renal Disease Undergoing Dialysis. Results from a Tertiary Centre in UK - A Retrospective Observational Audit
ISTH Academy, Faculty / Presenters, 407683
PB0508 Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Patients with β-Thalassemia: A Multicenter Analysis from the Extension-Myocardial Iron Overload in Thalassemia Network
ISTH Academy, Faculty / Presenters, 407684
PB0509 Timing of Anticoagulants in Patients with Venous Thromboembolism after Recent Intracerebral Hemorrhage
ISTH Academy, Faculty / Presenters, 407685
PB0504 Clinical Usefulness of Risk Tools Predicting Recurrence of Unprovoked Venous Thromboembolism: A Systematic Review and Meta-Analysis
ISTH Academy, Faculty / Presenters, 407686
PB0505 Outcomes of Patients with Pulmonary Embolism Admitted to the Intensive Care Unit
ISTH Academy, Faculty / Presenters, 407687
PB0495 Apixaban Use in Abdominal Transplant Recipients at a Large Academic Medical Center
ISTH Academy, Faculty / Presenters, 407688
PB0496 Bleeding Risk with Long-Term Fondaparinux Use for Secondary Prevention of Thromboembolism at a Tertiary Centre in the UK: A Retrospective Observational Audit
ISTH Academy, Faculty / Presenters, 407689
PB0497 Care Bundle for Management of Venous Thromboembolism: A Systematic Review
ISTH Academy, Faculty / Presenters, 407690
PB0498 Clinical Outcomes of Iliofemoral DVTs Associated with May-Thurner Syndrome
ISTH Academy, Faculty / Presenters, 407691
PB0499 Do All Patients with Acute Pulmonary Embolism Classified as Low Risk Based on a Simplified PESI are Truly at Low Risk of In-Hospital Adverse Outcomes?
ISTH Academy, Faculty / Presenters, 407692
PB0500 Edoxaban for Acute and Long-Term Treatment of Venous Thromboembolism: Real-Life Data from a Single Center Cohort Study
ISTH Academy, Faculty / Presenters, 407693
PB0501 Effect of High-Normal Renal Function on Apixaban Plasma Levels for Venous Thromboembolism Treatment in Obese Patients with BMI>40 Kg/M2
ISTH Academy, Faculty / Presenters, 407694
PB0502 Factors Associated with Outpatient Treatment among Patients with Low-Risk Pulmonary Embolism
ISTH Academy, Faculty / Presenters, 407695
PB0503 Patient Perspectives on Barriers and Facilitators to Warfarin Patient Self-Management in the US Healthcare System
ISTH Academy, Faculty / Presenters, 407696
PB0494 Defining the Optimal Cutoff Value of Gen-5 High-Sensitivity Troponin for the Risk-Stratification of Patients with Acute Pulmonary Embolism
ISTH Academy, Faculty / Presenters, 407697
PB0489 Different Oral Anticoagulants Have Distinct Interference in Thrombin Generation Parameters
ISTH Academy, Faculty / Presenters, 407698
PB0490 Does a Machine Learning Based Algorithm Improve Dosing of Vitamin K Antagonists Compared to Current Decision Support Programs?
ISTH Academy, Faculty / Presenters, 407699
PB0491 Patients from Different Settings Receiving Unfractionated Heparin (DEXHEP Study): Impact of PF4 on Anti-Xa Levels
ISTH Academy, Faculty / Presenters, 407700
PB0492 Review of Edoxaban Plasma Concentrations from King's College Hospital, UK
ISTH Academy, Faculty / Presenters, 407701
PB0493 Top 10 VTE Research Priorities of Patients and Clinicians: Clot Top 10 Priorities Results
ISTH Academy, Faculty / Presenters, 407702
PB0486 Effect of Age on Risk for Recurrent Venous Thromboembolism: A Systematic Review and Meta-Analysis
ISTH Academy, Faculty / Presenters, 407703
PB0487 Homozygous AT Deficiency Type II Heparin-Binding Site (HBS) - False Increase in the Level of Antithrombin Depending on the Concentration of the Direct Inhibitor of Activated Factor X (Apixaban)
ISTH Academy, Faculty / Presenters, 407704
PB0488 Interaction between Rivaroxaban, Apixaban or Edoxaban with Tacrolimus in Lung Transplant Recipients with Venous Thromboembolism (VTE)
ISTH Academy, Faculty / Presenters, 407705
PB0481 A Randomized Controlled Trial to Evaluate the Efficacy of an 8-Week Standardized Exercise Training Program for Preventing Post- Pulmonary Embolism Syndrome: Rationale & Design of the PE@HOME Study
ISTH Academy, Faculty / Presenters, 407706

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings